Zhe-Yu Hu
Overview
Explore the profile of Zhe-Yu Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hu Z, Zheng C, Yang J, Ding S, Tian C, Xie N, et al.
Front Oncol
. 2022 Mar;
12:804466.
PMID: 35280756
Background: In triple-negative breast cancer (TNBC), PDL1/PD1-directed immunotherapy is effective in less than 20% of patients. In our preliminary study, we have found CSPG4 to be highly expressed together with...
12.
Xie N, Hu X, Tang Y, Tian C, He Y, Hu Z, et al.
BMJ Open
. 2022 Feb;
12(2):e054135.
PMID: 35105583
Objectives: Although primary tumour surgery could prolong survival for patients with stage IV breast cancer, how to select candidates for primary tumour surgery is still a challenging problem for medical...
13.
Zhou D, Liu L, Liu J, Tang Y, Xiao M, Wang Y, et al.
Transl Oncol
. 2021 Oct;
14(12):101226.
PMID: 34614466
No abstract available.
14.
Huang X, Li X, Li J, Hu Z, Luo L, Tan Y, et al.
Tohoku J Exp Med
. 2021 Jun;
254(2):111-121.
PMID: 34162779
Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of cancer treatment. The factors influencing CINV in breast cancer patients remain unclear. In this study, we developed a nomogram...
15.
Huang Y, Cai C, Zang J, Xie J, Xu D, Zheng F, et al.
Aging (Albany NY)
. 2021 Apr;
13(8):12294.
PMID: 33927065
No abstract available.
16.
Hu Z, Liu L, Xie N, Lu J, Liu Z, Tang Y, et al.
Front Genet
. 2020 Nov;
11:829.
PMID: 33193564
is an important BRCAx candidate for familial breast cancers (FBC). pathogenic variants (PVs) may not to conform to "two hit" paradigm. However, a recent study demonstrates that in the majority...
17.
Huang Y, Cai C, Zang J, Xie J, Xu D, Zheng F, et al.
Aging (Albany NY)
. 2020 Jun;
12(12):11224-11237.
PMID: 32554861
With the outbreak of coronavirus disease-19 (COVID-19), Changsha faced an increasing burden of treating the Wuhan migrants and their infected patients. This study is a retrospective, single-center case series of...
18.
Xie N, Tian C, Wu H, Yang X, Liu L, Li J, et al.
Ther Adv Med Oncol
. 2020 Jun;
12:1758835920915305.
PMID: 32499836
Background: The survival status of patients with breast cancer and brain metastasis (BCBM) receiving current treatments is poor. Method: We designed a real-world study to investigate using patients' clinical and...
19.
Wu J, Su H, Yu Z, Xi S, Guo C, Hu Z, et al.
Cancer Cell Int
. 2020 Mar;
20:71.
PMID: 32165861
Background: Gliomas represent the largest class of primary central nervous system neoplasms, many subtypes of which exhibit poor prognoses. Surgery followed by radiotherapy and chemotherapy has been used as a...
20.
Tang Y, Li J, Xie N, Yang X, Liu L, Wu H, et al.
Aging (Albany NY)
. 2020 Jan;
12(2):1577-1590.
PMID: 31980592
Nearly half of metastatic breast cancers (MBC) have genetic aberrations in the PI3K/AKT pathway. To investigate the distinct effect of these aberrations on MBC, 193 MBC patients who progressed after...